Covington has advised OrbiMed. Goodwin Procter has advised Intellia Therapeutics. OrbiMed, a global healthcare investment firm, has entered into a non-dilutive senior secured term loan facility...
OrbiMed Provides $400 Million Non-Dilutive Debt Facility to Intellia Therapeutics
Q32 Bio Raises $55 Million in Private Placement
Goodwin Procter LLP has advised Q32 Bio Inc. WilmerHale has advised the placement agents. Q32 Bio Inc. (Nasdaq: QTTB), a clinical stage biotechnology company, has completed...
Windward Bio Group Secures USD 165 Million in Series B Financing Round
Homburger has advised Windward Bio Group AG. Wilson Sonsini Goodrich & Rosati and BGParnter have advised OrbiMed, Novo Holdings, Blue Owl Healthcare Opportunities, and Omega Funds....
OrbiMed Closes $1.86 Billion Healthcare Royalty and Credit Fund V
Gunderson Dettmer has advised OrbiMed. OrbiMed has completed the formation of its OrbiMed Royalty and Credit Opportunities Fund V, securing $1.86 billion in commitments. The fund...
Myriad Genetics Secures $200 Million Credit Facility
Covington has advised OrbiMed on the transaction. OrbiMed, a leading global healthcare investment firm, has provided a five-year senior secured term loan credit facility of up...
vVARDIS Group’s $35 Million Financing Round
Walder Wyss advised the funds managed by OrbiMed Advisors LLC on the deal. vVARDIS, a Swiss high growth dental company, and OrbiMed, a leading healthcare investment...
Helicore Biopharma’s $65 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Versant Ventures and OrbiMed on the transaction. Helicore Biopharma, a biopharmaceutical company focused on the discovery and development of first-in-class...
OrbiMed Advisors’ $208 Million Acquisition of Neurelis
Covington & Burling advised an affiliate of OrbiMed Advisors on the transaction. OrbiMed Advisors announced its agreement to purchase 100% of Neurelis Inc.’s rights, royalty interests,...
OrbiMed’s Financing Agreement with Poxel
OrbiMed was advised by LPA-CGR, BCLP, and Covington & Burling. Dechert LLP (Paris and New York) advised Poxel. OrbiMed announced it has entered into a non-dilutive...
OrbiMed’s $50 Million Financing
Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
OrbiMed’s $4.3 Billion Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented OrbiMed on the transaction. OrbiMed announced it has raised more than $4.3 billion in commitments for its latest private investment...
OrbiMed’s $125 Million Debt Financing
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...